{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:30:48Z","timestamp":1794475848263,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,12]],"date-time":"2027-05-12T00:00:00Z","timestamp":1810080000000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32CA251072"],"award-info":[{"award-number":["T32CA251072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ygyno.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:57:10Z","timestamp":1778551030000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy"],"prefix":"10.1016","volume":"209","author":[{"given":"Eliya","family":"Shachar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilat","family":"Rotkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Frankenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Demirjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Roscow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.05.007_bb0005","series-title":"NCCN Clinical Practice Guidelines in Oncology: [Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate]","author":"National Comprehensive Cancer Network","year":"2026"},{"issue":"14","key":"10.1016\/j.ygyno.2026.05.007_bb0010","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian Cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2026.05.007_bb0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"US Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"issue":"27","key":"10.1016\/j.ygyno.2026.05.007_bb0020","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.19.00363","article-title":"Update on genetic testing in gynecologic Cancer","volume":"37","author":"Domchek","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.05.007_bb0025","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations","volume":"8","author":"Eleje","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.007_bb0030","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ygyno.2026.05.007_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.007_bb0040","doi-asserted-by":"crossref","unstructured":"Specifying the ovarian cancer risk threshold of \u2018premenopausal risk-reducing salpingo-oophorectomy\u2019 for ovarian cancer prevention: a cost-effectiveness analysis | Journal of Medical Genetics. Accessed June 29, 2025. https:\/\/jmg.bmj.com\/content\/53\/9\/591","DOI":"10.1136\/jmedgenet-2016-103800"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.007_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/OP.21.00382","article-title":"Risk-reducing bilateral Salpingo-oophorectomy for ovarian Cancer: a review and clinical guide for hereditary predisposition genes","volume":"18","author":"Liu","year":"2022","journal-title":"JCO Oncol Pract."},{"key":"10.1016\/j.ygyno.2026.05.007_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.critrevonc.2016.10.008","article-title":"Routine use of gene panel testing in hereditary breast cancer should be performed with caution","volume":"108","author":"van Marcke","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"26","key":"10.1016\/j.ygyno.2026.05.007_bb0055","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in patients with newly diagnosed advanced ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.007_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.41165","article-title":"Antitumor activity and safety of Dostarlimab monotherapy in patients with mismatch repair deficient solid tumors: a nonrandomized controlled trial","volume":"6","author":"Andr\u00e9","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"22","key":"10.1016\/j.ygyno.2026.05.007_bb0065","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2026.05.007_bb0070","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database","volume":"67","author":"M\u00f8ller","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.007_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective lynch syndrome database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2026.05.007_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2025.08.016","article-title":"Germline landscape of high grade serous ovarian cancer across age groups: is age just a number?","volume":"201","author":"Sia","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.05.007_bb0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/gim.2012.67","article-title":"Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice","volume":"14","author":"Kolor","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2026.05.007_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1462831","article-title":"Awareness, use, motivations and methods of accessing genetic testing in 2022 in the United States","volume":"15","author":"Makhnoon","year":"2024","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.007_bb0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2026.05.007_bb0110","unstructured":"Genetic counseling referral frequency and attrition for newly diagnosed epithelial ovarian cancer at Grady Memorial Hospital from 2012\u20132022. - ASCO. Accessed March 28, 2026. https:\/\/www.asco.org\/abstracts-presentations\/223439"},{"issue":"15","key":"10.1016\/j.ygyno.2026.05.007_bb0115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast Cancer patients and ovarian Cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.007_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2022.08.043","article-title":"Disparities in biomarker testing in ovarian cancer: a real-world analysis","volume":"228","author":"Smith","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.007_bb0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","article-title":"Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers","volume":"177","author":"Heemskerk-Gerritsen","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"18","key":"10.1016\/j.ygyno.2026.05.007_bb0130","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.20.00299","article-title":"Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology guideline","volume":"38","author":"Tung","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.007_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1470-2045(25)00152-4","article-title":"Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study","volume":"26","author":"Blondeaux","year":"2025","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.007_bb0140","doi-asserted-by":"crossref","DOI":"10.5867\/medwave.2018.04.7160","article-title":"Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women\u2019s BRCA carriers","volume":"18","author":"Honold","year":"2018","journal-title":"Medwave"},{"issue":"15","key":"10.1016\/j.ygyno.2026.05.007_bb0145","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","article-title":"Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a Meta-analysis and systematic review","volume":"22","author":"Li","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.007_bb0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2014.55.8536","article-title":"Short-term risk of colorectal Cancer in individuals with lynch syndrome: a Meta-analysis","volume":"33","author":"Jenkins","year":"2015","journal-title":"JCO"},{"issue":"3 Part 1","key":"10.1016\/j.ygyno.2026.05.007_bb0160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","article-title":"Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations","volume":"108","author":"Schmeler","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"29","key":"10.1016\/j.ygyno.2026.05.007_bb0165","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer risks for PMS2-associated lynch syndrome","volume":"36","author":"ten Broeke","year":"2018","journal-title":"JCO"},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.007_bb0175","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","article-title":"Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies","volume":"3","author":"NAJ","year":"2017","journal-title":"JAMA. Oncol."},{"issue":"35","key":"10.1016\/j.ygyno.2026.05.007_bb0180","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with lynch syndrome","volume":"30","author":"Engel","year":"2012","journal-title":"JCO"},{"key":"10.1016\/j.ygyno.2026.05.007_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian Cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.007_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.007_bb0195","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2018.13152","article-title":"Prevalence of variant reclassification following hereditary cancer genetic testing","volume":"320","author":"Mersch","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.05.007_bb0200","article-title":"Impact of a cancer gene variant reclassification program over a 20-year period","volume":"4","author":"Esterling","year":"2020","journal-title":"JCO Precis. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:59:42Z","timestamp":1794473982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826019815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S0090825826019815"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}